Maria J de Miguel Luken (Maria de Miguel, Maria J de Miguel)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Combination Therapy

Placebo Controlled

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II study to determine the anti-tumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, Michael J Pishvaian, Yung-Jue Bang, Michael S Gordon, Ahmad Awada, D Ross Camidge, F Stephen Hodi, Grant A McArthur, Wilson H Miller, Andres Cervantes, Laura Q M Chow, Alexander M Lesokhin, Annemie Rutten, Mario Sznol, Deepali Rishipathak, Shang-Chiung Chen, Eric G Stefanich, Tony Pourmohamad, Maria Anderson, Jeong Kim, Mahrukh Huseni, Ina Rhee, Lillian L Siu
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Ana Luiza Gomes de Morais, Sara Cerdá, Maria J de Miguel Luken
New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors. Current oncology reports 24 (5) (2022)
Antoine Hollebecque, Hyun C Chung, Maria J de Miguel Luken, Antoine Italiano, Jean-Pascal Machiels, Chia-Chi Lin, Neesha C Dhani, Marc Peeters, Victor Moreno, Wu-Chou Su, Kay Hoong Chow, Violeta R Galvao, Michelle Carlsen, Danni Yu, Anna M Szpurka, Yumin Zhao, Shelly L Schmidt, Leena Gandhi, Xiaojian Xu, Yung-Jue Bang
Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Maria J de Miguel Luken, Pablo Umana, Ana Luiza Gomes de Morais, Victor Moreno, Emiliano Calvo
T-cell-engaging Therapy for Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2020)
Amita Patnaik, Timothy Anthony Yap, Hyun Cheol Chung, Maria J de Miguel Luken, Yung-Jue Bang, Chia-Chi Lin, Wu-Chou Su, Antoine Italiano, Kay Hoong Chow, Anna M Szpurka, Danni Yu, Yumin Zhao, Michelle Carlsen, Shelly Schmidt, Burkhard Vangerow, Leena Gandhi, Xiaojian Xu, Johanna Bendell
Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)